Collectively, these data show that in breast cancer patients, circulating NKT cell number may not correlate with function and provide a subset of biomarkers TNF-α, LAG3, and LIGHT, which can be used to assess immune function. This evidence concerns the gene TNFSF14 and breast carcinoma.